TFC Financial Management’s West Pharmaceutical WST Stock Holding History

TFC Financial Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08K	Hold	3	–	–	﹤0.01%	642
2026 Q1	$752	Hold	3	–	–	﹤0.01%	644
2025 Q4	$826	Hold	3	–	–	﹤0.01%	628
2025 Q3	$787	Hold	3	–	–	﹤0.01%	655
2025 Q2	$657	Buy	3 +2	+200%	+$428	﹤0.01%	638
2025 Q1	$224	Sell	1 -1	-50%	-$276	﹤0.01%	719
2024 Q4	$656	Hold	2	–	–	﹤0.01%	617
2024 Q3	$601	Buy	+2	New	+$612	﹤0.01%	640
2024 Q2	–	Sell	-3	Closed	-$1.19K	–	1113
2024 Q1	$1.19K	Buy	3 +1	+50%	+$370	﹤0.01%	527
2023 Q4	$705	Hold	2	–	–	﹤0.01%	555
2023 Q3	$751	Hold	2	–	–	﹤0.01%	555
2023 Q2	$765	Hold	2	–	–	﹤0.01%	537
2023 Q1	$693	Buy	+2	New	+$584	﹤0.01%	545
2022 Q1	–	Sell	-23	Closed	-$11K	–	590
2021 Q4	$11K	Hold	23	–	–	﹤0.01%	334
2021 Q3	$10K	Buy	23 +7	+44%	+$2.95K	﹤0.01%	336
2021 Q2	$6K	Hold	16	–	–	﹤0.01%	363
2021 Q1	$5K	Hold	16	–	–	﹤0.01%	372
2020 Q4	$5K	Hold	16	–	–	﹤0.01%	370
2020 Q3	$4K	Buy	+16	New	+$4.23K	﹤0.01%	358

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

TFC Financial Management's WST Position: Q2 2026 in Review

TFC Financial Management held its West Pharmaceutical (WST) position steady in Q2 2026 at 3 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #642.

TFC Financial Management first reported a position in WST in Q3 2020 and has held it in 19 quarters since. The position peaked at $11K in Q4 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

TFC Financial Management held 3 shares of West Pharmaceutical worth $1.08K as of Q2 2026.
TFC Financial Management left its West Pharmaceutical share count unchanged in Q2 2026.
West Pharmaceutical made up ﹤0.01% of TFC Financial Management's portfolio in Q2 2026, its #642 holding.
TFC Financial Management first reported a position in West Pharmaceutical in Q3 2020 and has held it in 19 quarters since.
TFC Financial Management's West Pharmaceutical position peaked at $11K in Q4 2021.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.